Search research articles
Contact Us
Filters
Showing results (91-100 of 117) with videos related to
Page
of 12
Sort By:
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.
European Urology
|
June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
J Connor Wells, Igor Stukalin, Craig Norton, et al.
European Urology
|
October 22, 2022
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2016
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Jose Manuel Ruiz-Morales, Marcin Swierkowski, J Connor Wells, et al.
Journal of Geriatric Oncology
|
March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis
Daniel V Araujo, J Connor Wells, Aaron R Hansen, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2022
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
Lucia Carril-Ajuria, Aude Desnoyer, Maxime Meylan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2021
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stéphane Terry, Cécile Dalban, Nathalie Rioux-Leclercq, et al.
International Journal of Cancer
|
July 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma
Juan M Roldan-Romero, Benoit Beuselinck, María Santos, et al.
European Urology
|
June 17, 2014
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
Daniel Y C Heng, J Connor Wells, Brian I Rini, et al.
European Urology Oncology
|
August 15, 2019
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Jeffrey Graham, J Connor Wells, Frede Donskov, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 117) with videos related to
Sort By:
Page
of 12
Kidney Cancer (Clifton, Va.)
|
October 19, 2018
Outcomes of Metastatic Chromophobe Renal Cell Carcinoma (chrRCC) in the Targeted Therapy Era: Results from the International Metastatic Renal Cell Cancer Database Consortium (IMDC)
Steven M Yip, Jose M Ruiz Morales, Frede Donskov, et al.
European Urology
|
June 20, 2016
Third-line Targeted Therapy in Metastatic Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
J Connor Wells, Igor Stukalin, Craig Norton, et al.
European Urology
|
October 22, 2022
Upfront Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma Treated with Immune Checkpoint Inhibitors or Targeted Therapy: An Observational Study from the International Metastatic Renal Cell Carcinoma Database Consortium
Ziad Bakouny, Talal El Zarif, Shaan Dudani, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 4, 2016
First-line sunitinib versus pazopanib in metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Jose Manuel Ruiz-Morales, Marcin Swierkowski, J Connor Wells, et al.
Journal of Geriatric Oncology
|
March 6, 2021
Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) - an International mRCC Database Consortium (IMDC) analysis
Daniel V Araujo, J Connor Wells, Aaron R Hansen, et al.
Journal for Immunotherapy of Cancer
|
May 31, 2022
Baseline circulating unswitched memory B cells and B-cell related soluble factors are associated with overall survival in patients with clear cell renal cell carcinoma treated with nivolumab within the NIVOREN GETUG-AFU 26 study
Lucia Carril-Ajuria, Aude Desnoyer, Maxime Meylan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 19, 2021
Association of AXL and PD-L1 Expression with Clinical Outcomes in Patients with Advanced Renal Cell Carcinoma Treated with PD-1 Blockade
Stéphane Terry, Cécile Dalban, Nathalie Rioux-Leclercq, et al.
International Journal of Cancer
|
July 24, 2019
PTEN expression and mutations in TSC1, TSC2 and MTOR are associated with response to rapalogs in patients with renal cell carcinoma
Juan M Roldan-Romero, Benoit Beuselinck, María Santos, et al.
European Urology
|
June 17, 2014
Cytoreductive nephrectomy in patients with synchronous metastases from renal cell carcinoma: results from the International Metastatic Renal Cell Carcinoma Database Consortium
Daniel Y C Heng, J Connor Wells, Brian I Rini, et al.
European Urology Oncology
|
August 15, 2019
Cytoreductive Nephrectomy in Metastatic Papillary Renal Cell Carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium
Jeffrey Graham, J Connor Wells, Frede Donskov, et al.
Page
of 12